1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ELOVL1 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA ZNF628 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA NOL4 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA SYT2 CTRPv2 pan-cancer AAC 0.1 0.001
mRNA ACVR1 CTRPv2 pan-cancer AAC -0.13 0.001
mRNA TBC1D10C CTRPv2 pan-cancer AAC 0.13 0.001
mRNA SLCO4A1 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA NSL1 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA ALG3 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA THUMPD2 CTRPv2 pan-cancer AAC 0.11 0.001
Download CSV